Skip to main content
Pharmanutra logo

Pharmanutra — Investor Relations & Filings

Ticker · PHN ISIN · IT0005274094 LEI · 815600F8217BC7733697 XMIL Manufacturing
Open in API
Filings indexed 601 across all filing types
Latest filing 2023-04-05 AGM Information
Country IT Italy
Listing XMIL PHN

About Pharmanutra

http://www.pharmanutra.it

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Recent filings

Filing Released Lang Actions
PHARMANUTRA - CS - Pubblicazione lista e documenti per assemblea
AGM Information Classification · 1% confidence The document is an official communication (Informazione Regolamentata) from PHARMANUTRA S.P.A. dated April 5, 2023. The subject line explicitly states: 'PHARMANUTRA - CS - Pubblicazione lista e documenti per assemblea' (Publication of list and documents for the meeting). The body confirms the publication of proposals for resolutions and the list of candidates for the Board of Directors for the Ordinary Shareholders' Meeting scheduled for April 26, 2023. It also mentions that documentation, including the 'Relazione sulla politica di remunerazione ed i compensi corrisposti' (Remuneration Report), is available. Since the document's primary purpose is to announce the availability of materials (lists, proposals, and supporting documents) for an upcoming shareholder meeting, it strongly aligns with the definition of materials related to the Annual General Meeting (AGM). While it mentions remuneration reports (DEF 14A content), the overarching context is the preparation for the AGM. The most specific and encompassing category for materials related to the AGM, including candidate lists and related proposals, is AGM-R (AGM Information). It is not the final voting results (DVA) nor the proxy solicitation itself (PSI), but the announcement of the materials for the meeting.
2023-04-05 Italian
Pharmanutra - Report on Corporate Governance and Ownership structure_2022
Governance Information Classification · 1% confidence The document explicitly titles itself as a "REPORT ON CORPORATE GOVERNANCE AND OWNERSHIP STRUCTURE OF PHARMANUTRA S.P.A." for the Financial Year 2022. It references specific Italian regulations, notably Article 123bis of Italian Legislative Decree no. 58/1998 (TUF), which mandates the content of such reports. The table of contents details sections on 'INFORMATION ON THE OWNERSHIP STRUCTURE', 'COMPLIANCE', 'BOARD OF DIRECTORS', 'COMMITTEES WITHIN THE BOARD OF DIRECTORS', and 'INTERNAL CONTROL AND RISK MANAGEMENT SYSTEM'. These elements strongly align with the definition of a Governance Information report, which details internal rules, board structure, and governance practices. This matches the 'Governance Information (Code: CGR)' definition.
2023-03-31 English
Pharmanutra - Relazione sul Governo Societario e gli assetti proprietari_Esercizio 2022
Governance Information Classification · 1% confidence The document is titled "RELAZIONE SUL GOVERNO SOCIETARIO E GLI ASSETTI PROPRIETARI DI PHARMANUTRA S.P.A." (Report on Corporate Governance and Shareholding Structure of Pharmanutra S.p.A.) for the fiscal year 2022. It explicitly states it was prepared pursuant to art. 123 bis of Legislative Decree 58/1998 (TUF - Testo Unico della Finanza) and approved by the Board of Directors on March 16, 2023. Article 123-bis of the TUF mandates the annual Corporate Governance Report. The table of contents details sections covering capital structure, board composition, internal controls, and related party transactions, which are standard components of a Corporate Governance Report. This aligns perfectly with the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices, often mandated by regulations like Article 123-bis.
2023-03-31 Italian
Pharmanutra - Annual Financial report
Annual Report Classification · 1% confidence The document is explicitly titled 'ANNUAL FINANCIAL REPORT' for the period ending December 31st 2022. It contains comprehensive financial statements, management reports, explanatory notes, and an independent auditor's report for the PharmaNutra Group. This aligns perfectly with the definition of a 10-K (Annual Report). FY 2022
2023-03-31 English
Pharmanutra - Relazione finanziaria annuale
Annual Report Classification · 1% confidence The document is titled 'RELAZIONE FINANZIARIA ANNUALE' (Annual Financial Report) for the period ending December 31, 2022. It contains comprehensive financial statements, including the consolidated balance sheet, income statement, cash flow statement, and detailed explanatory notes for both the Group and the parent company (PharmaNutra S.p.A.). It also includes the management report (Relazione sulla gestione) and audit information. This aligns perfectly with the definition of an Annual Report (10-K equivalent for international markets). FY 2022
2023-03-31 Italian
Pharmanutra - Relazione finanziaria annuale / Annual financial report
Report Publication Announcement Classification · 1% confidence The document is an official notice from Pharmanutra S.p.A. titled "AVVISO DI DEPOSITO RELAZIONE FINANZIARIA ANNUALE AL 31.12.2022" (NOTICE OF DEPOSIT OF THE 2022 ANNUAL FINANCIAL REPORT). The subject line explicitly mentions "Relazione finanziaria annuale / Annual financial report". However, the text itself states that the report is available at various locations and directs the reader to see the attachment ("Vedi allegato"). The document length is relatively short (6850 chars) and its primary function is to announce the availability of the full Annual Financial Report, rather than being the report itself. According to Rule #2 (The "MENU VS MEAL" Rule), a short announcement stating that a report has been published or is attached should be classified as a Report Publication Announcement (RPA). The content confirms the availability of the Annual Financial Report, which would typically be a 10-K, but this specific document is the announcement of its publication.
2023-03-31 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.